Research Paper Volume 16, Issue 2 pp 1733—1749
Identification and validation of methylation-CpG prognostic signature for prognosis of hepatocellular carcinoma
Figure 3. Molecular and immune function analysis among HPSM groups. (A) Enriched gene sets among the HPSM-high group. (B) Enriched gene sets among the HPSM-low group. (C, D) GSEA of HPSM subgroups in survival-related gene sets. (E) GSEA enrichment analysis of HPSM subgroups in immune-related gene sets. (F) Scores of 29 tumor-infiltrating immune cell subsets and immune-related functions. (G) TMB analysis in HPSM-low groups. (H) TMB analysis in HPSM-high groups.